Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifecore Biomedical, Inc. - Common Stock (NQ:LFCR)

5.715 -0.515 (-8.27%)
Streaming Delayed Price Updated: 3:15 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lifecore Biomedical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Announces Special Stockholder Meeting
Company Seeking to Remove Convertible Preferred Stock Exchange Cap to Permit Potential Conversion of Series A Preferred Stock as Contemplated by the Series A Preferred Stock Terms 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025
Webcast Scheduled for Thursday, January 2 at 4:30 p.m. Eastern 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Hosts Virtual Investor Day
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Present at Stephens Annual Investment Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
PIPE with New and Existing Investors Supports Working Capital and Operations 
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
From Lifecore Biomedical, Inc.
Via GlobeNewswire
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. (LFCR)
From The Law Offices of Frank R. Cruz
Via Business Wire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
From Faruqi & Faruqi LLP
Via GlobeNewswire
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
From Lifecore Biomedical, Inc.
Via GlobeNewswire
LFCR FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important September 27 Deadline in Securities Class Action – LFCR
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore
From Faruqi & Faruqi LLP
Via GlobeNewswire
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, DexCom, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
LIFECORE BIOMEDICAL, INC. (NASDAQ: LFCR) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Lifecore Biomedical, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lifecore, Spire Global, Oddity Tech, and Arbor Realty and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Faruqi & Faruqi Reminds Lifecore Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 27, 2024 - LFCR
From Faruqi & Faruqi LLP
Via GlobeNewswire
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
From Lifecore Biomedical, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.